tiprankstipranks
AngioGenex Inc (AGGX)
OTHER OTC:AGGX
US Market

AngioGenex (AGGX) Financial Statements

0 Followers

AngioGenex Financial Overview

AngioGenex's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; AngioGenex is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 19Mar 19Dec 18Sep 18Jun 18
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -145.24K$ -576.83K$ -94.42K$ -78.16K$ -86.10K
EBITDA$ -145.24K$ -576.83K$ -94.42K$ -78.16K$ -86.10K
Net Income Common Stockholders$ -147.38K$ -579.28K$ -85.67K$ -80.63K$ -88.21K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 96.91K$ 95.38K$ 19.58K$ 117.34K$ 251.38K
Total Assets$ 112.11K$ 119.66K$ 52.82K$ 148.59K$ 255.38K
Total Debt$ 152.12K$ 156.20K$ 156.20K$ 156.20K$ 156.20K
Net Debt$ 55.20K$ 60.82K$ 136.62K$ 38.86K$ -95.18K
Total Liabilities$ 1.24M$ 1.18M$ 1.12M$ 1.14M$ 1.17M
Stockholders Equity$ -1.13M$ -1.06M$ -1.07M$ -993.42K$ -915.64K
Cash Flow-
Free Cash Flow$ -61.29K$ -116.28K$ -92.57K$ -128.93K$ -119.50K
Operating Cash Flow$ -61.29K$ -116.28K$ -92.57K$ -128.93K$ -119.50K
Investing Cash Flow-----
Financing Cash Flow$ 62.82K$ 192.08K$ -5.19K$ -5.12K$ -10.00K
Currency in USD

AngioGenex Earnings and Revenue History

AngioGenex Debt to Assets

AngioGenex Cash Flow

AngioGenex Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis